Citation Impact
Citing Papers
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
2016
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
2002
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery
2013
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Synthesis, structure and biological activity of nickel(II) complexes of 5-methyl 2-furfural thiosemicarbazone
2001
Guidelines on the radical management of patients with lung cancer
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
2009
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Lung Cancer
2008 Standout
Peak Oxygen Consumption During Cardiopulmonary Exercise Test Improves Risk Stratification in Candidates to Major Lung Resection
2008
Exercise Standards for Testing and Training
2013 Standout
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery
2006
Video-Assisted Thoracic Surgery Pulmonary Resection for Lung Cancer in Patients with Poor Lung Function
2006
Receptor-mediated targeting of 67Ga-Deferoxamine-Folate to folate-receptor-positive human kb tumor xenografts
1999
Lung cancer: New biological insights and recent therapeutic advances
2011
Second line chemotherapy for NSCLC: establishing a gold standard
2002
Cancer nanotechnology: opportunities and challenges
2005 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine)
2005
Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis
2015
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Hydrogen Storage in Microporous Metal–Organic Frameworks with Exposed Metal Sites
2008 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals
2003
Synthesis and characterization of branched poly(l-glutamic acid) as a biodegradable drug carrier
2003
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Acute toxicity and mutagenicity of the copper complex of pyruvaldehyde‐bis (N‐4‐methylthiosemicarbazone), Cu‐PTSM
1990
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Diffusing Capacity Predicts Morbidity After Lung Resection in Patients Without Obstructive Lung Disease
2008
Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals
2011
Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non-Small-Cell Lung Cancer
2005
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Medication-Induced Hyperprolactinemia
2005
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates
2005
Folate-mediated targeting: from diagnostics to drug and gene delivery
2001
Novel Functional Hyperbranched Polyether Polyols as Prospective Drug Delivery Systems
2006
Copper radionuclides and radiopharmaceuticals in nuclear medicine
1996
Microtubules as a target for anticancer drugs
2004 Standout
Exercise Testing and Training in Chronic Lung Disease and Pulmonary Arterial Hypertension
2011
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review
2011
Targeted drug delivery via the folate receptor
2000
Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands
1999
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Design, synthesis and characterization of a Pt–Gd metal–organic framework containing potentially catalytically active sites
2008
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
2005
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
2002
Small-cell lung cancer
2011
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
2010
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
2004
Isoreticular Metalation of Metal−Organic Frameworks
2009 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Studies on the Mechanism of Hypoxic Selectivity in Copper Bis(Thiosemicarbazone) Radiopharmaceuticals
2002
Near-Infrared Light Photocontrolled Targeting, Bioimaging, and Chemotherapy with Caged Upconversion Nanoparticles in Vitro and in Vivo
2013
Bonding and structure trends of thiosemicarbazone derivatives of metals—An overview
2008 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
A critical review of the literature on acrolein toxicity
1985
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
Current and Prospective Protein Biomarkers of Lung Cancer
2017
Structural trends in copper(ii ) bis(thiosemicarbazone) radiopharmaceuticals
2003
Stepwise assembly of platinum–folic acid conjugates
2007
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer
2006
Preoperative evaluation of the lung cancer resection candidate
2010
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Nonviral Vectors for Gene Delivery
2008 Standout
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
2011
Structural modification strategies for the rational design of red/NIR region BODIPYs
2014 Standout
Spectral and Structural Studies of the Copper(II) Complexes of 3, 4‐Hexanedione Bis(3‐azacyclothiosemicarbazones)
2003
Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
2012
A “Click Chemistry” Approach to the Efficient Synthesis of Multiple Imaging Probes Derived from a Single Precursor
2009
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer
2007
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
2015
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
2001
Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data
2011
Labeling of Sperm Cells via the Spontaneous Penetration of Eu3+ Ions as Nanoparticles Complexed with PVA or PVP
2008
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Poly(ethylene glycol)-mediated Steric Stabilization of Complexes Formed between Negatively Charged Liposomes and Folate-conjugated Poly(amidoamine) Dendrimers in Water
2008
Cy3-Cy5 Covalent Heterodimers for Single-Molecule Photoswitching
2008 StandoutNobel
Enhanced Tumor Detection Using a Folate Receptor-Targeted Near-Infrared Fluorochrome Conjugate
2003
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
2017
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Synthesis, characterization, crystal structure and electrochemical behavior of a nickel(II) complex of 5,6-dihydro-2H-pyran-3-aldehyde thiosemicarbazone
2005
Design of Dendritic Macromolecules Containing Folate or Methotrexate Residues
1999
Hypoxia-Targeting Copper Bis(selenosemicarbazone) Complexes: Comparison with Their Sulfur Analogues
2003
Cardiopulmonary Exercise Testing in the Clinical Evaluation of Patients With Heart and Lung Disease
2011
Synthesis, structural and spectral studies of 5-methyl 2-furaldehyde thiosemicarbazone and its Co, Ni, Cu and Cd complexes
2001
Metal Insertion in a Microporous Metal−Organic Framework Lined with 2,2′-Bipyridine
2010 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Novel synthesis of [18F]‐fluorobenzene and pyridinecarbohydrazide‐folates as potential PET radiopharmaceuticals
2005
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
2010
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Copper(II) complexes 1-phenylpropane-1,2-dione- and benzil bis(3-piperidylthiosemicarbazone): A structural study
2003
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
MegaStokes BODIPY-triazoles as environmentally sensitive turn-on fluorescent dyes
2013
Synthesis of Target-Specific Radiolabeled Peptides for Diagnostic Imaging
2002
Metal–Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal–Organic Materials
2012 Standout
Structural and spectral studies of nickel(II), copper(II) and cadmium(II) complexes of 3-furaldehyde thiosemicarbazone
2004
Structural and spectral study of platinum(II) complexes of pyridil bis{3-piperidyl-, bis{hexamethyleneiminyl-, bis{N(4)-diethyl- and bis{N(4)-dipropylthiosemicarbazones}
2001
Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art.
2015
The Future of Aerobic Exercise Testing in Clinical Practice: is It the Ultimate Vital sign?
2010
A Metal−Organic Framework with Covalently Bound Organometallic Complexes
2010 StandoutNobel
Works of Mark A. Green being referenced
Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
1998
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects
2009
Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood
2003
Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study
2005
Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins
2008
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238
2007
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals
2008
Suppressed Prolactin Response to Dynorphin A1–13 in Methadone-Maintained Versus Control Subjects
2003
Structural characterization of a metal-based perfusion tracer: Copper(II) pyruvaldehyde bis (N4-methylthiosemicarbazone)
1989
Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
2011
Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105
2008
Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
2008
Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial
2000
Design and Synthesis of [111In]DTPA−Folate for Use as a Tumor-Targeted Radiopharmaceutical
1997
The effects of acetaldehyde and acrolein on blood pressure in guanethidine-pretreated hypertensive rats
1983
Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
2009
cis-3,4-Diaminocyclopentanol complexes of platinum(II)
2000
Structural and spectral studies of copper(II) and nickel(II) complexes of pyruvaldehyde mixed bis{N(4)-substituted thiosemicarbazones}
1999
Synthesis, Purification, and Tumor Cell Uptake of 67Ga-Deferoxamine−Folate, a Potential Radiopharmaceutical for Tumor Imaging
1996